| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| Gross Profit | $0 | -100.0% |
| R&D Expense | $201K | — |
| SG&A Expense | $362K | +636.7% |
| Operating Income | -$41.0M | — |
| Net Income | -$40.9M | -4030.8% |
| EPS (Basic) | -$2.73 | -149.4% |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $156K | +13.8% |
| Inventory | $0 | -100.0% |
| Current Assets | $287K | +70.3% |
| Total Assets | $44.0M | — |
| Current Liabilities | $29.8M | +7229.9% |
| Total Liabilities | $41.1M | — |
| Stockholders' Equity | $2.9M | +1368.7% |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.1M | — |
| Capital Expenditures | $3K | — |
| Investing Cash Flow | -$853K | — |
| Financing Cash Flow | $4.0M | +2566.7% |
| Free Cash Flow | -$3.1M | — |